- Abstract:
-
Adherence to evidence-based guidelines for the secondary prevention of coronary heart disease (CHD) has been shown to be poor in a number of surveys. In this open-label, non-comparative 17-week trial, 399 patients with existing CHD and LDL cholesterol concentration > 3.4 mmol/l (130 mg/dl) were treated with atorvastatin 10 mg daily. After 5 weeks, the dose of atorvastatin was adjusted according to a patient's LDL cholesterol level. Of the 379 patients remaining in the study after five week...
Expand abstract - Journal:
- International journal of clinical practice
- Volume:
- 53
- Issue:
- 6
- Pages:
- 422-426
- Publication date:
- 1999-09-05
- EISSN:
-
1742-1241
- ISSN:
-
1368-5031
- URN:
-
uuid:96b53238-a373-472a-bf17-b1c8669b8c98
- Source identifiers:
-
72845
- Local pid:
- pubs:72845
- Copyright date:
- 1999
Journal article
An assessment of the efficacy of atorvastatin in achieving LDL cholesterol target levels in patients with coronary heart disease: a general practice study.
Actions
Authors
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record